Showing results (911-920 of 924) with videos related to

Sort By:
Pageof 93
Journal of Medicinal Chemistry|October 23, 2013
Discovery of GS-9669, a thumb site II non-nucleoside inhibitor of NS5B for the treatment of genotype 1 chronic hepatitis C infectionScott E Lazerwith, Willard Lew, Jennifer Zhang, et al.
Developmental Cell|July 30, 2014
EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4Ruey-Hwang Chou, Ying-Nai Wang, Yi-Hsien Hsieh, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2025
Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly IndividualsPin-Shiuan Chen, Yi-Ling Liu, Pu-Tien Chiang, et al.
Antimicrobial Agents and Chemotherapy|November 28, 2012
Preclinical characterization of GS-9669, a thumb site II inhibitor of the hepatitis C virus NS5B polymeraseMartijn Fenaux, Stacey Eng, Stephanie A Leavitt, et al.
Journal of Medicinal Chemistry|January 12, 2017
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin AVictoria A Steadman, Simon B Pettit, Karine G Poullennec, et al.
Endoscopy|October 13, 2025
A rural-to-center artificial intelligence model for diagnosing Helicobacter pylori infection and premalignant gastric conditions using endoscopy images captured in routine practiceTsung-Hsien Chiang, Yen-Ning Hsu, Min-Han Chen, et al.
Clinical and Molecular Hepatology|July 13, 2021
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosisChen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, et al.
Gut|January 7, 2021
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairmentChen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, et al.
Hepatology International|March 7, 2021
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in TaiwanChen-Hua Liu, Po-Yueh Chen, Jyh-Jou Chen, et al.
Hepatology International|January 26, 2023
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in TaiwanChen-Hua Liu, Cheng-Yuan Peng, Chun-Jen Liu, et al.
Pageof 93